Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/05/20
Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This FallThe Motley Fool • 05/05/20
Regeneron Earnings Easily Beat Views; Biotech Giant Stock Near HighsInvestors Business Daily • 05/05/20
Regeneron earnings beat expectations, plans to begin human studies of COVID-19 treatment in JuneMarket Watch • 05/05/20
Regeneron (REGN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/28/20
Positive Cancer Trial Results Offset a COVID-19 Flop for Regeneron and SanofiThe Motley Fool • 04/27/20
Regeneron and Sanofi’s arthritis drug shows no benefit in non-critical COVID-19 patientsInvezz • 04/27/20
Regeneron, Sanofi Say Kevzara Will Now Only Be Tested in Sickest COVID-19 PatientsThe Motley Fool • 04/27/20
Regeneron, Sanofi say Kevzara will only be tested in sickest COVID-19 patientsMarket Watch • 04/27/20
Regeneron, Sanofi arthritis drug shows benefit for sickest coronavirus patients, but not for less- advanced casesCNBC • 04/27/20
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?The Motley Fool • 04/24/20
4 Stocks That Performed Very Well Following The 1/23 Senate Classified Intelligence Briefing.Forbes • 04/21/20